Table 1 Summary of sequencing data and mapped results in the study

(%)

Total

mapped

reads

Uniquely

mapped

reads

After

fasting

control group

muscle

C-1-M

a

15314862

15128756

97.33

14059595 (92.93%)

13217716 (87.37%)

b

14823783

14646957

97.41

13619629 (92.99%)

12843759 (87.69%)

c

16321214

16109369

97.33

14958284 (92.85%)

14160730

(87.9%)

liver

C-1-L

a

14438249

14251753

96.49

13182134 (92.49%)

12514167 (87.81%)

b

17127547

16903996

96.56

15592380 (92.24%)

14753416 (87.28%)

c

14523380

14310106

96.5

13233306 (92.48%)

12636047

(88.3%)

experimental group

muscle

E-1-M

a

14988606

14778249

96.82

13616046 (92.14%)

13093152

(88.6%)

b

17791102

17541598

96.93

16214273 (92.43%)

15661812 (89.28%)

c

14762762

14589546

96.98

13498507 (92.52%)

12890714 (88.36%)

liver

E-1-L

a

16289196

16107092

97.55

14933900 (92.72%)

14405289 (89.43%)

b

11491146

11345300

97.52

10536721 (92.87%)

10183044 (89.76%)

c

17191329

16972319

97.38

15807590 (93.14%)

15308206

(90.2%)

After re-feeding

control group

muscle

C-2-M

a

19323422

18945419

97.6

17275859 (91.19%)

16426146

(86.7%)

b

17903385

17565549

97.62

15988557 (91.02%)

15240472 (86.76%)

c

21096997

20647765

97.63

18828972 (91.19%)

17985183

(87.1%)

liver

C-2-L

a

17502755

17349119

97.56

16078785 (92.68%)

15316916 (88.29%)

b

17230237

17050272

97.52

15895193 (93.23%)

15188285 (89.08%)

c

16617660

16399951

97.5

15177704 (92.55%)

14472205 (88.25%)

experimental group

muscle

E-2-M

a

12796800

12303323

95.99

11089012 (90.13%)

10562927 (85.85%)

b

20644903

19733726

95.82

17856999 (90.49%)

17012127 (86.21%)

c

16427709

15639982

95.88

14047696 (89.82%)

13295885 (85.01%)

liver

E-2-L

a

13892743

13713405

97.42

12794265 (93.3%)

12273895

(89.5%)

b

17895233

17661014

97.42

16454496 (93.17%)

15843241 (89.71%)

c

15687125

15496141

97.43

14440618 (93.19%)

13845040 (89.35%)